A business in context

MYGN research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-16 · 0002082246-26-000008

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000899923-26-000072

  3. 8-K · Current report

    Report date 2026-07-30 · 0000899923-26-000070 · Items 2.02,9.01

  4. 4 · Ownership change

    Report date 2026-06-23 · 0001628280-26-044911

  5. 8-K · Current report

    Report date 2026-06-17 · 0000899923-26-000062 · Items 5.02

  6. 4 · Ownership change

    Report date 2026-06-11 · 0002065630-26-000006

  7. 4 · Ownership change

    Report date 2026-06-11 · 0001738340-26-000006

  8. 4 · Ownership change

    Report date 2026-06-08 · 0001824720-26-000004

  9. 4 · Ownership change

    Report date 2026-06-04 · 0002024613-26-000002

  10. 4 · Ownership change

    Report date 2026-06-04 · 0001824720-26-000002

  11. 4 · Ownership change

    Report date 2026-06-04 · 0001788981-26-000002

  12. 8-K · Current report

    Report date 2026-06-04 · 0000899923-26-000059 · Items 5.02,5.07,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000899923-26-000038

  14. 8-K · Current report

    Report date 2026-05-05 · 0000899923-26-000036 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0000899923-26-000031

  16. 10-K · Annual report

    Report date 2025-12-31 · 0000899923-26-000018

  17. 8-K · Current report

    Report date 2026-02-23 · 0000899923-26-000012 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-01-12 · 0000899923-26-000003 · Items 2.02,9.01

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000899923-25-000112

  20. 8-K/A · Current report

    Report date 2025-11-03 · 0000899923-25-000109 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2025-11-03 · 0000899923-25-000103 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-10-01 · 0000899923-25-000096 · Items 5.02,9.01

  23. 8-K · Current report

    Report date 2025-09-29 · 0000899923-25-000091 · Items 5.02

  24. 8-K · Current report

    Report date 2025-08-15 · 0000899923-25-000089 · Items 5.02,9.01

  25. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000899923-25-000086

  26. 8-K · Current report

    Report date 2025-08-05 · 0000899923-25-000084 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-07-31 · 0000899923-25-000072 · Items 1.01,2.03,8.01,9.01

  28. 8-K · Current report

    Report date 2025-06-05 · 0000899923-25-000066 · Items 5.02,5.07,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000899923-25-000048

  30. 8-K · Current report

    Report date 2025-05-06 · 0000899923-25-000045 · Items 2.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0000899923-25-000028

  32. 10-K · Annual report

    Report date 2024-12-31 · 0000899923-25-000019

  33. 8-K · Current report

    Report date 2025-02-24 · 0000899923-25-000010 · Items 2.02,5.02,7.01,9.01

  34. 8-K · Current report

    Report date 2025-01-15 · 0000899923-25-000002 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2024-12-10 · 0000899923-24-000065 · Items 5.02,9.01

  36. 8-K · Current report

    Report date 2024-11-26 · 0000899923-24-000060 · Items 7.01,9.01

  37. SC 13G/A · Ownership disclosure

    0000905148-24-003139

  38. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000899923-24-000057

  39. 8-K · Current report

    Report date 2024-11-07 · 0000899923-24-000054 · Items 2.02,9.01

  40. 8-K · Current report

    Report date 2024-10-09 · 0000899923-24-000048 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 1 transaction rows1PSale: 1 transaction rows1SGrant / award: 11 transaction rows11AExercise / conversion: 0 transaction rows0MTax / exercise payment: 3 transaction rows3FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

16 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-11
2026-06-12
Donnelly Brian JA · Grant / award
Acquired
Common Stock5000.03.94
2026-06-11
2026-06-12
Raha Samraat S.A · Grant / award
Acquired
Common Stock3542.03.94
2026-06-08
2026-06-09
Kumar Rashmi
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15000.04.46
2026-06-04
2026-06-05
Davis Mark StevenA · Grant / award
Acquired
Common Stock59701.00.0
2026-06-04
2026-06-05
Kumar RashmiA · Grant / award
Acquired
Common Stock59701.00.0
2026-06-04
2026-06-05
Newcomer Lee NisleyA · Grant / award
Acquired
Common Stock59701.00.0
2026-06-04
2026-06-05
Reitan Colleen FA · Grant / award
Acquired
Common Stock59701.00.0
2026-06-04
2026-06-05
Skovronsky DanielA · Grant / award
Acquired
Common Stock59701.00.0
2026-06-04
2026-06-05
Phanstiel S. LouiseA · Grant / award
Acquired
Common Stock59701.00.0
2026-06-04
2026-06-05
Dreismann HeinrichA · Grant / award
Acquired
Common Stock59701.00.0
2026-06-04
2026-06-05
Bisaro PaulA · Grant / award
Acquired
Common Stock59701.00.0
2026-06-01
2026-06-02
Jampa RajA · Grant / award
Acquired
Common Stock251889.00.0
2026-05-14
2026-05-14
Bisaro PaulP · Purchase
Acquired
Common Stock7500.03.69
2026-05-01
2026-05-04
Donnelly Brian JF · Tax / exercise payment
Disposed
Common Stock55975.04.8
2026-04-14
2026-04-15
Muzzey DaleF · Tax / exercise payment
Disposed
Common Stock946.04.91
2026-04-14
2026-04-15
Verratti MarkF · Tax / exercise payment
Disposed
Common Stock1069.04.91

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000899923MYRIAD GENETICS INC
Myriad Genetics (Germany)Myriad Rules-Based Medicine (United States)

Showing 2 of 2 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
52990044IHUOUMETT163
GLEIF legal name
Myriad Genetics, Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2021-07-14T05:31:46Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Myriad Genetics · alias · wikidata
  • Myriad Genetics (Germany) · subsidiary · wikidata
  • Myriad Rules-Based Medicine (United States) · subsidiary · wikidata
  • MYRIAD GENETICS INC · former SEC name · 1996-11-14 to 2026-09-04
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$837.60M$891.59M
2023-12-31$753.20M$825.37M
2022-12-31$678.40M$773.92M
2021-12-31$690.60M$850.89M
2020-12-31$557.10M$718.76M
2020-06-30$638.60M$829.00M
2019-06-30$851.10M$1.12B
2018-06-30$743.70M$1.00B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗